Hypertension Research最新文献_第4页

The control rate of hypertension across months of year and hours of day in a large real-world database. 大型真实世界数据库中不同月份和不同时段的高血压控制率。

IF 4.3 2区医学

Hypertension Research Pub Date : 2024-08-21 DOI: 10.1038/s41440-024-01817-1

Qinghua Yan, Minna Cheng, Wenli Xu, Yibang Cheng, Fei Wu, Yuheng Wang, Qinping Yang, Yan Shi, Jiguang Wang

{"title":"The control rate of hypertension across months of year and hours of day in a large real-world database.","authors":"Qinghua Yan, Minna Cheng, Wenli Xu, Yibang Cheng, Fei Wu, Yuheng Wang, Qinping Yang, Yan Shi, Jiguang Wang","doi":"10.1038/s41440-024-01817-1","DOIUrl":"https://doi.org/10.1038/s41440-024-01817-1","url":null,"abstract":"We investigated the control rate of hypertension across months of year and hours of day in a real-world database. The study participants were hypertensive patients from 142 community health centers across 16 districts in Shanghai, China, who measured their blood pressure with an automatic office blood pressure measurement platform between 2018 and 2023. The 343,400 hypertensive patients included 53.7% of women, and had average age of 70.2 (±8.1) years (range 50-90 years). For months of year, the control rate of hypertension was lowest in February and highest in August (51.9% vs 71.8%). For hours of day, the control rate of hypertension was lowest at 7:00 AM and highest at 12:00 PM (52.1% vs 76.0%). When the months of year and hour of day were considered together, the control rate was lowest at 7 AM in February (42.1%), and highest at 12 PM in July (86.8%). In 8516 patients who had uncontrolled blood pressure in the early morning and had their blood pressure also measured around noon, 45.7% had masked uncontrolled morning hypertension, with higher rates in spring and summer, and in women, those aged 50-69 years, and non-diabetic patients. The control rate of hypertension varies greatly across months of year and hours of day, suggesting that the evaluation of blood pressure control has to take into full consideration the measurement time in terms of months and hours.","PeriodicalId":13029,"journal":{"name":"Hypertension Research","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142017285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Depressive symptoms and the development of hypertension. 抑郁症状与高血压的发展

IF 4.3 2区医学

Hypertension Research Pub Date : 2024-08-21 DOI: 10.1038/s41440-024-01856-8

Taku Inoue

引用次数: 0

Maternal exposure to LPS results in overactivation of renal sympathetic nerve activity and hypertension in offspring rats. 母体暴露于 LPS 会导致子代大鼠肾交感神经活性过度激活和高血压。

IF 4.3 2区医学

Hypertension Research Pub Date : 2024-08-21 DOI: 10.1038/s41440-024-01828-y

Ruy R Campos

引用次数: 0

Twenty-year trends of potentially avoidable hospitalizations for hypertension in Switzerland. 瑞士可避免的高血压住院治疗二十年趋势。

IF 4.3 2区医学

Hypertension Research Pub Date : 2024-08-21 DOI: 10.1038/s41440-024-01853-x

Pedro Marques-Vidal, Ko Ko Maung, Alexandre Gouveia

{"title":"Twenty-year trends of potentially avoidable hospitalizations for hypertension in Switzerland.","authors":"Pedro Marques-Vidal, Ko Ko Maung, Alexandre Gouveia","doi":"10.1038/s41440-024-01853-x","DOIUrl":"https://doi.org/10.1038/s41440-024-01853-x","url":null,"abstract":"We assessed the trends, characteristics, and consequences of potentially avoidable hospitalizations (PAH) for hypertension in Switzerland, for the period 1998 to 2018. Data from 117,507 hospitalizations (62.1% women), minimum age 20 years. Hospitalizations with hypertension as the main cause for admission were eligible. PAH for hypertension was defined according to the Organization for Economic Cooperation and Development criteria. The age-standardized rates of PAH for hypertension increased from 43 in 1998 to 81 per 100,000 in 2004, to decrease to 57 per 100,000 inhabitants in 2018. Compared to non-PAH, patients with PAH for hypertension were younger, more frequently women (66.9% vs. 56.7%), non-Swiss nationals (15.9% vs. 10.9%), were more frequently admitted as an emergency (78.9% vs. 59.5%), and by the patient's initiative (33.1% vs. 14.1%). Patients with PAH had also fewer comorbidities, as per the Charlson's index. Patients with PAH for hypertension were more frequently hospitalized in a semi-private or private setting, stayed less frequently in the intensive care unit (4.6% vs. 7.3%), were discharged more frequently home (91.4% vs. 73.0%), and had a shorter length of stay than patients with non-PAH for hypertension: median and [interquartile range] 5 [3-8] vs. 9 [4-15] days. In 2018, the total costs of PAH were estimated at 16.5 million CHF, corresponding to a median cost of 4936 [4445-4961] Swiss Francs per stay. We conclude that in Switzerland, PAH have increased, represent a considerable fraction of hospitalizations for hypertension, and carry a non-negligible health cost.","PeriodicalId":13029,"journal":{"name":"Hypertension Research","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142017286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Hypertension and atrial fibrillation: the clinical impact of hypertension on perioperative outcomes of atrial fibrillation ablation and its optimal control for the prevention of recurrence. 高血压与心房颤动：高血压对心房颤动消融术围手术期结果的临床影响及其预防复发的最佳控制方法。

IF 4.3 2区医学

Hypertension Research Pub Date : 2024-08-16 DOI: 10.1038/s41440-024-01796-3

Masashi Kamioka, Keisuke Narita, Tomonori Watanabe, Hiroaki Watanabe, Hisaki Makimoto, Takafumi Okuyama, Ayako Yokota, Takahiro Komori, Tomoyuki Kabutoya, Yasushi Imai, Kazuomi Kario

{"title":"Hypertension and atrial fibrillation: the clinical impact of hypertension on perioperative outcomes of atrial fibrillation ablation and its optimal control for the prevention of recurrence.","authors":"Masashi Kamioka, Keisuke Narita, Tomonori Watanabe, Hiroaki Watanabe, Hisaki Makimoto, Takafumi Okuyama, Ayako Yokota, Takahiro Komori, Tomoyuki Kabutoya, Yasushi Imai, Kazuomi Kario","doi":"10.1038/s41440-024-01796-3","DOIUrl":"https://doi.org/10.1038/s41440-024-01796-3","url":null,"abstract":"Hypertension (HTN) is one of the major risk factors for developing atrial fibrillation (AF), and it has been estimated that approximately 70% of hypertensive patients are at risk of developing AF. On the other hand, 60-80% of AF patients have HTN. These two diseases share many risk factors such as diabetes mellitus, obesity, alcohol consumption, and sleep apnea syndrome during their onset and disease progression. The mutual presence of these diseases has the potential to create a negative spiral, exacerbating each other's impact and ultimately leading to cardiovascular events such as heart failure and cerebrovascular disorders, thereby increasing mortality rates. With regard to the treatment of HTN, the variety of antihypertensive drugs and treatment options have significantly increased. Alongside the widespread adoption of antihypertensive therapy, a certain level of efficacy has been recognized in suppressing the incidence of new-onset AF. Catheter ablation is an established and effective treatment for AF. However, a notable recurrence rate persists. In recent years, management of these multiple risk factors has been recognized to be essential for suppressing AF recurrence, and recent guidelines for AF underscore the significance of proactively managing these risks before treatment. Notably, effective HTN management assumes paramount importance given its impact on the morbidity of AF patients. This review summarizes the correlation between HTN control before and after ablation and the risk of AF recurrence. The focus is on elucidating the pathophysiological background and its impact on clinical outcomes.","PeriodicalId":13029,"journal":{"name":"Hypertension Research","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141995659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Absolute cardiovascular risk assessment using 'real world' clinic blood pressures compared to standardized unobserved and ambulatory methods: an observational study. 使用 "真实世界 "门诊血压与标准化非观察法和门诊血压进行绝对心血管风险评估比较：一项观察性研究。

IF 4.3 2区医学

Hypertension Research Pub Date : 2024-08-16 DOI: 10.1038/s41440-024-01841-1

Niamh Chapman, Senali Jayasinghe, Myles N Moore, Dean S Picone, Martin G Schultz, Matthew D Jose, Roland W McCallum, Matthew K Armstrong, Xiaoqing Peng, Thomas H Marwick, Philip Roberts-Thomson, Nathan B Dwyer, J Andrew Black, Mark R Nelson, James E Sharman

{"title":"Absolute cardiovascular risk assessment using 'real world' clinic blood pressures compared to standardized unobserved and ambulatory methods: an observational study.","authors":"Niamh Chapman, Senali Jayasinghe, Myles N Moore, Dean S Picone, Martin G Schultz, Matthew D Jose, Roland W McCallum, Matthew K Armstrong, Xiaoqing Peng, Thomas H Marwick, Philip Roberts-Thomson, Nathan B Dwyer, J Andrew Black, Mark R Nelson, James E Sharman","doi":"10.1038/s41440-024-01841-1","DOIUrl":"https://doi.org/10.1038/s41440-024-01841-1","url":null,"abstract":"Clinic blood pressure (BP) is recommended for absolute cardiovascular disease (CVD) risk assessment. However, in 'real-world' settings, clinic BP measurement is unstandardised and less reliable compared to more rigorous methods but the impact for absolute CVD risk assessment is unknown. This study aimed to determine the difference in absolute CVD risk assessment using real-world clinic BP compared to standardised BP methods. Participants were patients (n = 226, 59 ± 15 years; 58% female) with hypertension referred to a BP clinic for assessment. 'Real-world' clinic BP was provided by the referring doctor. All participants had unobserved automated office BP (AOBP) and 24-h ambulatory BP monitoring (ABPM) measured at the clinic. Absolute CVD risk was calculated (Framingham) using systolic BP from the referring doctor (clinic BP), AOBP and ABPM, with agreement assessed by Kappa statistic. Clinic systolic BP was 18 mmHg than AOBP and daytime ABPM and 22 mmHg higher than 24-h ABPM (p < 0.001). Subsequently, absolute CVD risk scores using clinic BP were higher compared to AOBP, daytime ABPM and 24-h ABPM (10.4 ± 8.1%, 7.8 ± 6.4%, 7.8 ± 6.3%, and 7.3 ± 6.1%, respectively, P < 0.001). As a result, more participants were classified as high CVD risk using clinic BP (n = 89, 40%) compared with AOBP (n = 44, 20%) daytime ABPM (n = 38, 17%) and 24-h ABPM (n = 38, 17%) (p < 0.001) with weak agreement in risk classification (κ = 0.57[0.45-0.69], κ = 0.52[0.41-0.64] and κ = 0.55[0.43-0.66], respectively). Real-world clinic BP was higher and classified twice as many participants at high CVD risk compared to AOBP or ABPM. Given the challenges to high-quality BP measurement in clinic, more rigorous BP measurement methods are needed for absolute CVD risk assessment.","PeriodicalId":13029,"journal":{"name":"Hypertension Research","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141995656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Do angiotensin-converting enzyme inhibitors not reduce the risk of pneumonia? 血管紧张素转换酶抑制剂不会降低肺炎风险吗？

IF 4.3 2区医学

Hypertension Research Pub Date : 2024-08-16 DOI: 10.1038/s41440-024-01848-8

Shunichiro Tsukamoto

引用次数: 0

Hypertension phenotypes and adverse pregnancy outcome-related office and ambulatory blood pressure thresholds during pregnancy: a retrospective cohort study. 妊娠期高血压表型与不良妊娠结局相关的诊室和门诊血压阈值：一项回顾性队列研究。

IF 4.3 2区医学

Hypertension Research Pub Date : 2024-08-16 DOI: 10.1038/s41440-024-01837-x

Yiwen Fang, Lushu Zuo, Hongli Duan, Chuanyi Huang, Jiying Wen, Qing Yang, Cha Han, Lijuan Lv, Xin Zhou

{"title":"Hypertension phenotypes and adverse pregnancy outcome-related office and ambulatory blood pressure thresholds during pregnancy: a retrospective cohort study.","authors":"Yiwen Fang, Lushu Zuo, Hongli Duan, Chuanyi Huang, Jiying Wen, Qing Yang, Cha Han, Lijuan Lv, Xin Zhou","doi":"10.1038/s41440-024-01837-x","DOIUrl":"https://doi.org/10.1038/s41440-024-01837-x","url":null,"abstract":"Blood pressure (BP) phenotypes, as determined by the consistency between office BP (OBP) and ambulatory BP (ABP) measurements, enhance risk assessment during pregnancy. However, diagnostic criteria for hypertension in pregnancy are based on data from non-pregnant populations regarding long-term cardiovascular risks. This study aimed to identify adverse pregnancy outcomes (APOs; including maternal/fetal outcomes)-related BP thresholds to refine risk assessment in pregnant women. We analyzed 967 high-risk pregnant women who underwent simultaneous OBP and ABP measurements at an average gestational age of 29.6 ± 8.0 weeks. All hypertension phenotypes were associated with an increased risk of maternal and fetal outcomes, except white coat hypertension, which showed no association with fetal outcomes. Using an XGBoost algorithm, the receiver operating characteristic (ROC) curve-derived daytime diastolic BP (DBP) thresholds of 81.5 mmHg for maternal and 82.5 mmHg for fetal outcomes were identified as the BP parameters most strongly linked to APOs. Incorporating these thresholds into the BP phenotype-based model improved the area under the curve for APOs and the net reclassification index for maternal and fetal outcomes. Decision curve analysis demonstrated a consistent positive net benefit after incorporating BP thresholds into the phenotype-based model for maternal and composite outcomes. In conclusion, in a Chinese pregnancy cohort, we identified daytime DBP as the most influential parameter for APOs, significantly enhancing the predictive performance of BP phenotype-based models. This study underscores the importance of ABP monitoring in high-risk pregnancies and the need for further research to establish optimal BP monitoring criteria for pregnancy.","PeriodicalId":13029,"journal":{"name":"Hypertension Research","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141995660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Assessment of blood pressure variability: characteristics and comparison of blood pressure measurement methods. 血压变异性评估：血压测量方法的特点和比较。

IF 4.3 2区医学

Hypertension Research Pub Date : 2024-08-16 DOI: 10.1038/s41440-024-01844-y

Keisuke Narita, Daichi Shimbo, Kazuomi Kario

{"title":"Assessment of blood pressure variability: characteristics and comparison of blood pressure measurement methods.","authors":"Keisuke Narita, Daichi Shimbo, Kazuomi Kario","doi":"10.1038/s41440-024-01844-y","DOIUrl":"https://doi.org/10.1038/s41440-024-01844-y","url":null,"abstract":"Previous studies have reported that blood pressure variability (BPV) is associated with the risk of cardiovascular events independent of blood pressure (BP) levels. While there is little evidence from intervention trials examining whether suppressing BPV is useful in preventing cardiovascular disease, it is suggested that detection of abnormally elevated BPV may be useful in reducing cardiovascular events adding by complementing management of appropriate BP levels. Cuffless BP devices can assess beat-to-beat BPV. Although cuffless BP monitoring devices have measurement accuracy issues that need to be resolved, this is an area of research where the evidence is accumulating rapidly, with many publications on beat-to-beat BPV over several decades. Ambulatory BP monitoring (ABPM) can assess 24-hour BPV and nocturnal dipping patterns. Day-to-day BPV and visit-to-visit BPV are assessed by self-measured BP monitoring at home and office BP measurement, respectively. 24 h, day-to-day, and visit-to-visit BPV have been reported to be associated with cardiovascular prognosis. Although there have been several studies comparing whether ABPM and self-measured BP monitoring at home is the superior measurement method of BPV, no strong evidence has been accumulated that indicates whether ABPM or self-measured home BP is superior. ABPM and self-measured BP monitoring have their own advantages and complement each other in the assessment of BPV.","PeriodicalId":13029,"journal":{"name":"Hypertension Research","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141995657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Identification of causal candidates for pregnancy-induced hypertension through Bayesian model averaging-based Mendelian randomization. 通过基于贝叶斯模型平均法的孟德尔随机化，确定妊娠诱发高血压的因果候选者。

IF 4.3 2区医学

Hypertension Research Pub Date : 2024-08-16 DOI: 10.1038/s41440-024-01857-7

Satoshi Morimoto, Atsuhiro Ichihara

引用次数: 0